The insider transactions over the last year suggest optimism about the company's future. The level of insider ownership indicates a reasonable degree of alignment with common shareholders.
Christine Kho
OP
TinkerB3ll
:
assay quality issue and drop in Asia Pacific market share...technically bottom volumn > peak volumn is good entry price...purposely oversold...soon will see back to 8-9
Gainers •$MillerKnoll (MLKN.US)$+12.4%,$BioNTech (BNTX.US)$+7.4%,$Lululemon Athletica (LULU.US)$+6.5% (also authorizes $1 bln stock repurchase program) •$Adagio Therapeutics (ADGI.US)$+52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization) ...
18
8
2
Report
CraCra665
:
I'd personally go for the ones w the losses. because that when I gst in. on the dips. I'm not jumping into anything up like that. I maybe wrong. but that's how I feel. get in high when drop comes. ur in the negative. not a smart move in my mind.
RDK79
:
Very glad moomoo provides excellent business news, especially as CNBC transitions all of its business news to a WAY OVERPRICED ‘CNBC Pro’ service. Very little regular relevant business news via CNBC these days.
152398576 : your update made me a buck
Trytosaveabit OP 152398576 : That’s awesome congrats
! But you made the trade! I just pointed in the proper direction for a possible move! Hehehe